+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
All Genders
ID05641259

Evaluating Safety and Preliminary Effects of LP-108 with Azacitidine in Adults with AML, MDS, and CMML

Led by Guangzhou Lupeng Pharmaceutical Company LTD. · Updated on 2026-09-11

198

Participants Needed

3

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety, tolerability, and pharmacokinetics of LP-108, a BCL-2 inhibitor, combined with azacitidine in adults with acute myeloid leukemia AML, myelodysplastic syndromes MDS, or chronic myelomonocytic leukemia CMML. This Phase 1, open-label, multicenter study aims to determine the recommended Phase 2 dose and assess early signs of effectiveness in these conditions. Participants receive LP-108 orally for 21 or 28 days within a 28-day cycle, with azacitidine administered subcutaneously for 7 days each cycle starting on day 1, except during an initial ramp-up cycle. The study includes dose escalation and expansion phases, where dosing schedules are adjusted to identify tolerable and effective doses. Participants continue treatment until disease progression, unacceptable side effects, or other reasons for withdrawal. Strong or moderate CYP3A inhibitors and inducers are not allowed during the study. During the study, participants undergo screening to confirm eligibility and have regular blood and bone marrow tests. Researchers monitor safety events, pharmacokinetic parameters such as maximum concentration and half-life of LP-108, and response to treatment. Outcomes measured include maximum tolerated dose, objective response rate, progression-free survival, and overall survival, with follow-up lasting up to five years. Treatment and safety are closely monitored throughout the study duration.

CONDITIONS

Brief Title

A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML

Research Team

Y

Yue Shen, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here